Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity-Reference-Cited by-同舟云学术

Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity

Published:2001-03 Issue:1-3 Volume:120 Page:359-368
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Waring Jeffrey F.,Ciurlionis Rita,Jolly Robert A.,Heindel Matthew,Ulrich Roger G.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference41 articles.

1. Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2- and 4-hydroxylation of 17β-estradiol in female Sprague–Dawley rats;Badawi;Carcinogenesis,2000

2. Mechanism of hepatotoxicity to periportal regions of the liver lobule due to allyl alcohol: role of oxygen and lipid peroxidation;Badr;J. Pharmacol. Exp. Ther.,1986

3. Methotrexate hepatotoxicity;Barak;J. Am. Coll. Nutr.,1984

4. The production of periportal necrosis by allyl alcohol in the rat;Butterworth;Br. J. Pharmacol,1978

5. Hepatotoxicity in Wistar rats following chronic methotrexate administration: a model of human reaction;Custer;J. Natl. Cancer Inst.,1977

Cited by 273 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subchronic Toxicity Assessment of Zingiber roseum Rhizome in Mice Model: Safety Evaluation at Various Doses;Current Nutrition & Food Science;2024-10

2. Genome-wide gene expression analysis reveals molecular insights into the drug-induced toxicity of nephrotoxic agents;Life Sciences;2022-10

3. Comparison of toxicological effects and exposure levels between triclosan and its structurally similar chemicals using in vitro tests for read-across case study;Regulatory Toxicology and Pharmacology;2022-07

4. Therapeutic Drug Monitoring (TDM) and Toxicological Studies in Alternative Biological Matrices;Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology;2022

5. Toxicogenomics in drug safety assessment;Pharmacokinetics and Toxicokinetic Considerations;2022